146 related articles for article (PubMed ID: 32758579)
1. Ctnnb1 transcriptional upregulation compensates for Mdm2/p53-mediated β-catenin degradation in neutrophils following cardioembolic stroke.
Wang H; Zhou K; Li W; Du J; Xiao J
Gene; 2021 Jan; 766():145022. PubMed ID: 32758579
[TBL] [Abstract][Full Text] [Related]
2. Single-Nucleotide Polymorphism 309T>G in the MDM2 Promoter Determines Functional Outcome After Stroke.
Rodríguez C; Ramos-Araque ME; Domínguez-Martínez M; Sobrino T; Sánchez-Morán I; Agulla J; Delgado-Esteban M; Gómez-Sánchez JC; Bolaños JP; Castillo J; Almeida A
Stroke; 2018 Oct; 49(10):2437-2444. PubMed ID: 30355102
[TBL] [Abstract][Full Text] [Related]
3. MALAT1 Activates the P53 Signaling Pathway by Regulating MDM2 to Promote Ischemic Stroke.
Zhang T; Wang H; Li Q; Fu J; Huang J; Zhao Y
Cell Physiol Biochem; 2018; 50(6):2216-2228. PubMed ID: 30419554
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis of the CDK2 functions in neuroblastoma.
Bo L; Wei B; Wang Z; Kong D; Gao Z; Miao Z
Mol Med Rep; 2018 Mar; 17(3):3951-3959. PubMed ID: 29328425
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma.
Drakos E; Thomaides A; Medeiros LJ; Li J; Leventaki V; Konopleva M; Andreeff M; Rassidakis GZ
Clin Cancer Res; 2007 Jun; 13(11):3380-7. PubMed ID: 17545546
[TBL] [Abstract][Full Text] [Related]
6. Identification of key genes and transcription factors in aging mesenchymal stem cells by DNA microarray data.
Wu Y; Yang J; Ai Z; Yu M; Li J; Li S
Gene; 2019 Apr; 692():79-87. PubMed ID: 30641220
[TBL] [Abstract][Full Text] [Related]
7. MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway.
Zauli G; Rimondi E; Corallini F; Fadda R; Capitani S; Secchiero P
J Bone Miner Res; 2007 Oct; 22(10):1621-30. PubMed ID: 17592964
[TBL] [Abstract][Full Text] [Related]
8. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
[TBL] [Abstract][Full Text] [Related]
9. Excess beta-catenin promotes accumulation of transcriptionally active p53.
Damalas A; Ben-Ze'ev A; Simcha I; Shtutman M; Leal JF; Zhurinsky J; Geiger B; Oren M
EMBO J; 1999 Jun; 18(11):3054-63. PubMed ID: 10357817
[TBL] [Abstract][Full Text] [Related]
10. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
[TBL] [Abstract][Full Text] [Related]
11. Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation.
Hui W; Liu S; Zheng J; Fang Z; Ding Q; Feng C
Cancer Med; 2018 Apr; 7(4):1440-1449. PubMed ID: 29532999
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer.
Zhen YB; Guo XL; Xu B; Zhao HW; Xu CJ
Neoplasma; 2016; 63(6):856-864. PubMed ID: 27565323
[TBL] [Abstract][Full Text] [Related]
13. MDM2 mediates fibroblast activation and renal tubulointerstitial fibrosis via a p53-independent pathway.
Ye C; Tang H; Zhao Z; Lei CT; You CQ; Zhang J; Gao P; He FF; Chen S; Wang YM; Zhang C; Su H
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F760-F768. PubMed ID: 28100501
[TBL] [Abstract][Full Text] [Related]
14. p53 mediates the negative regulation of MDM2 by orphan receptor TR3.
Zhao BX; Chen HZ; Lei NZ; Li GD; Zhao WX; Zhan YY; Liu B; Lin SC; Wu Q
EMBO J; 2006 Dec; 25(24):5703-15. PubMed ID: 17139261
[TBL] [Abstract][Full Text] [Related]
15. Effects of β-catenin on differentially expressed genes in multiple myeloma.
Chen H; Chai W; Li B; Ni M; Zhang GQ; Liu HW; Zhang Z; Chen JY; Zhou YG; Wang Y
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):546-552. PubMed ID: 26223925
[TBL] [Abstract][Full Text] [Related]
16. Regulation of p53: intricate loops and delicate balances.
Oren M; Damalas A; Gottlieb T; Michael D; Taplick J; Leal JF; Maya R; Moas M; Seger R; Taya Y; Ben-Ze'ev A
Biochem Pharmacol; 2002 Sep; 64(5-6):865-71. PubMed ID: 12213580
[TBL] [Abstract][Full Text] [Related]
17. A Murine Model of K-RAS and β-Catenin Induced Renal Tumors Expresses High Levels of E2F1 and Resembles Human Wilms Tumor.
Yi Y; Polosukhina D; Love HD; Hembd A; Pickup M; Moses HL; Lovvorn HN; Zent R; Clark PE
J Urol; 2015 Dec; 194(6):1762-70. PubMed ID: 25934441
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke.
Zou R; Zhang D; Lv L; Shi W; Song Z; Yi B; Lai B; Chen Q; Yang S; Hua P
J Transl Med; 2019 Feb; 17(1):45. PubMed ID: 30760287
[TBL] [Abstract][Full Text] [Related]
19. Identification of Hub Genes Associated with Immune Infiltration in Cardioembolic Stroke by Whole Blood Transcriptome Analysis.
Li Q; Gao X; Luo X; Wu Q; He J; Liu Y; Xue Y; Wu S; Rao F
Dis Markers; 2022; 2022():8086991. PubMed ID: 35075378
[TBL] [Abstract][Full Text] [Related]
20. Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells.
Zhao K; Zhou Y; Qiao C; Ni T; Li Z; Wang X; Guo Q; Lu N; Wei L
J Hematol Oncol; 2015 Apr; 8():41. PubMed ID: 25902914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
